The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study. (Q53064700)
Jump to navigation
Jump to search
scientific article published in July 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study. |
scientific article published in July 2010 |
Statements
The safety and efficacy of biphasic insulin aspart 30 (BIAsp 30) in Iranians with type 2 diabetes: an open-label, non-randomised, multi-centre observational study--the Iran subgroup of the IMPROVE™ study (English)
Alireza Esteghamati
Reza Rajabian
Masoud Amini
Amir Bahrami
Mohammad Ebrahim Khamseh
Mohammad Afkhami-Ardekani
Ehsan Parvaresh Rizi